Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer

OBJECTIVE: This study aimed to investigate the efficacy and safety of anti-PD-1 immunotherapy combined with gemcitabine chemotherapy in multiline treatment of advanced pancreatic cancer. METHODS: A retrospective analysis was performed on the clinical data of 32 patients with advanced pancreatic canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanfeng, Li, Yanchuan, Du, Shan, Fan, Li, Wang, Junyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470333/
https://www.ncbi.nlm.nih.gov/pubmed/36110574
http://dx.doi.org/10.1155/2022/4070060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470333/
https://www.ncbi.nlm.nih.gov/pubmed/36110574
http://dx.doi.org/10.1155/2022/4070060

Ejemplares similares